Početna › Burkittov limfom › Washington › Seattle
Kliničke studije za Burkittov limfom u gradu Seattle, WA
11 studija za Burkittov limfom traži sudionike na lokacijama u gradu Seattle i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
U tijeku regrutacijaFaza 2
- Seattle Children's Hospital, Seattle
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
U tijeku regrutacijaFaza 2
- Seattle Children's Hospital, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
U tijeku regrutacijaFaza 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
U tijeku regrutacijaFaza 2
- Seattle Children's Hospital, Seattle
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
U tijeku regrutacijaFaza 3
- Seattle Children's Hospital, Seattle
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
U tijeku regrutacija
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
U tijeku regrutacijaFaza 1
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
U tijeku regrutacijaFaza 1
- Fred Hutchinson Cancer Research Center, Seattle
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
U tijeku regrutacijaFaza 1
- Fred Hutchinson Cancer Center, Seattle
Studije za Burkittov limfom u drugim gradovima
- Houston, TX21 studija
- Milwaukee, WI16 studija
- Philadelphia, PA16 studija
- New York City, NY14 studija
- Chicago, IL14 studija
- Cincinnati, OH12 studija
- Atlanta, GA12 studija
- Boston, MA10 studija
- Durham, NC10 studija
- Aurora, CO10 studija
- Los Angeles, CA10 studija
- Kansas City, MO10 studija
Ostale studije u gradu Seattle
- Nemikrocelularni karcinom pluća53 studija
- Rak (sve vrste)49 studija
- Rak prostate42 studija
- Akutna mijeloična leukemija40 studija
- Rak dojke39 studija
- Metastatski karcinom39 studija
- Kolorektalni rak34 studija
- Rak pluća33 studija
- Rak jajnika30 studija
- Multipli mijelom22 studija
- Mijelodisplastični sindromi21 studija
- Akutna limfoblastna leukemija21 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.